Mix and match = better patient satisfaction

Article

Mixing and matching the ReZoom (AMO) and Tecnis (AMO) multifocal intraocular lenses (IOLs) produces enhanced visual outcomes and patient satisfaction.

Mixing and matching the ReZoom (AMO) and Tecnis (AMO) multifocal intraocular lenses (IOLs) produces enhanced visual outcomes and patient satisfaction, according to Baha Toygar and colleagues from the Dunya Eye Hospital, Istanbul, Turkey.

In a concurrent case series, 11 refractive lens exchange (RLE) patients and three cataract patients were bilaterally implanted with ReZoom in the dominant eye and Tecnis in the fellow eye. One subject with high hyperopia underwent a piggyback IOL implantation. The target refraction for both multifocal IOLs was emmetropia.

At six-month follow-up, mean postoperative spherical equivalent (SE) was -0.11±0.47 D. Monocular uncorrected and best corrected distance visual acuity (VA) was 0.78±0.21 and 0.95±0.16, respectively. All patients, except for the patient receiving the piggyback implantation, could read 20/20 binocularly. Eighty-two percent of subjects achieved a near uncorrected VA of J2 or better and, when tested binocularly without correction, 100% of patients could read J2 or better, including 65% who achieved J1 or better. None of the patients reported halos or glare.

The researchers concluded from their study that the combination of the two lenses leads to enhanced visual outcomes and patient satisfaction.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.